Daniel Lange, Author at QuickBird Medical

Reimbursement of software in the GKV medical aids directory (HMV)

by Daniel Lange | Nov 3, 2026 | medical-software-whitepaper

Healthcare software manufacturers in Germany face a key challenge: How can digital solutions be used to generate revenue in the healthcare system? The market for privately paid products is small, and patients are often reluctant to pay for software out of their own...

Current DiGA Reports 2026: Official Reports at a glance

by Daniel Lange | Nov 2, 2026 | diga-whitepaper, Professional article for DiGA landing page

Where exactly can I find the latest figures and reports for approved digital health applications (DiGA)? For the strategic planning of new DiGA projects and market analyses, it is important to consider the prescription figures for listed DiGAs. However, when searching...

Innovation fund: Funding for digital health solutions

by Daniel Lange | Feb 11, 2026 | medical-software-whitepaper

Many manufacturers of medical software and health apps are faced with the question: How can digital solutions be used to build a sustainable business model? The market for self-paying patients in the German healthcare system is relatively small, and the path to...

DiGA as a Medical Device (MDR): Requirements & Differences

by Daniel Lange | Feb 9, 2026 | diga-whitepaper

Since 2019, around 73 million people with statutory health insurance in Germany have been entitled to digital health applications (DiGA): the so-called “app on prescription.” However, the interaction between DiGA and medical device regulations often causes confusion...

DiGA Revenue & Costs: Is a DiGA worthwhile?

by Daniel Lange | Jan 22, 2026 | diga-whitepaper, Professional article for DiGA landing page

As with any business idea, the financial potential of a DiGA project should be calculated at the outset. A central question arises: Is the development of your DiGA idea worthwhile for you? Potential investors for your DiGA project are also asking themselves this...